Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association between maternal inflammatory bowel disease and adverse perinatal outcomes

Abstract

Objective:

To examine whether inflammatory bowel disease (IBD) is associated with ischemic/inflammatory conditions during pregnancy.

Study Design:

A retrospective cohort study using the 2000 to 2012 Kaiser Permanente Southern California maternally-linked medical records (n=395 781). The two major subtypes of IBD, ulcerative colitis and Crohn’s diseases were studied. Adjusted odds ratios (ORs) were used to quantify the associations.

Result:

A pregnancy complicated by IBD was associated with increased incidence of small-for-gestational age birth (OR=1.46, 95% confidence interval (CI)=1.14 to 1.88), spontaneous preterm birth (OR=1.32, 95% CI=1.00 to 1.76) and preterm premature rupture of membranes (OR=1.95, 95% CI=1.26 to 3.02). Further stratifying by IBD subtypes, only ulcerative colitis was significantly associated with increased incidence of ischemic placental disease, spontaneous preterm birth and preterm premature rupture of membranes.

Conclusion:

The findings underscore the potential impact of maternal IBD on adverse perinatal outcomes. Clinicians should be aware that the association between IBD and adverse perinatal outcome varies by IBD subtypes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142 (1): 46–54 e42.

    Article  Google Scholar 

  2. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5 (12): 1424–1429.

    Article  Google Scholar 

  3. Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S et al. Review article: mycobacterium avium subsp. paratuberculosis as one cause of Crohn’s disease. Aliment Pharmacol Ther 2001; 15 (3): 337–346.

    Article  CAS  Google Scholar 

  4. Hermon-Taylor J . Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn’s disease. Gut 2001; 49 (6): 755–756.

    Article  CAS  Google Scholar 

  5. Ekbom A, Daszak P, Kraaz W, Wakefield AJ . Crohn’s disease after in-utero measles virus exposure. Lancet 1996; 348 (9026): 515–517.

    Article  CAS  Google Scholar 

  6. Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ . Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000; 12 (1): 25–30.

    Article  CAS  Google Scholar 

  7. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease(EC-IBD). Gut 1996; 39 (5): 690–697.

    Article  CAS  Google Scholar 

  8. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R et al. Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111 (3): 597–603.

    Article  CAS  Google Scholar 

  9. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008; 40 (8): 955–962.

    Article  CAS  Google Scholar 

  10. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101 (7): 1559–1568.

    Article  Google Scholar 

  11. Logan RF, Kay CR . Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989; 18 (1): 105–107.

    Article  CAS  Google Scholar 

  12. Kornfeld D, Cnattingius S, Ekbom A . Pregnancy outcomes in women with inflammatory bowel disease—a population-based cohort study. Am J Obstet Gynecol 1997; 177 (4): 942–946.

    Article  CAS  Google Scholar 

  13. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK et al. A meta-analysis on the influence of inflammatory bowel diseaseon pregnancy. Gut 2007; 56 (6): 830–837.

    Article  CAS  Google Scholar 

  14. Norgard B, Pedersen L, Christensen LA, Sorensen HT . Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102 (7): 1406–1413.

    Article  Google Scholar 

  15. Farmer RG, Hawk WA, Turnbull RB, Jr . Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 1975; 68 (4 Pt 1): 627–635.

    CAS  PubMed  Google Scholar 

  16. Kornbluth A, Sachar DB . Practice Parameters Committee of the American College of G. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99 (7): 1371–1385.

    Article  Google Scholar 

  17. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA . Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 1991; 165 (4 Pt 1): 955–961.

    Article  CAS  Google Scholar 

  18. Ananth CV, Peltier MR, Getahun D, Kirby RS, Vintzileos AM . Primiparity: an ‘intermediate’ risk group for spontaneous and medically indicated preterm birth. J Matern Fetal Neonatal Med 2007; 20 (8): 605–611.

    Article  Google Scholar 

  19. Getahun D, Rhoads GG, Fassett MJ, Chen W, Strauss JA, Demissie K et al. Accuracy of reporting maternal and infant perinatal service system coding and clinical utilization coding. J Med Stat Inform 2013; 1: 3.

    Article  Google Scholar 

  20. Wellcome Trust Case Control C Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447 (7145): 661–678.

    Article  Google Scholar 

  21. Dominitz JA, Young JC, Boyko EJ . Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97 (3): 641–648.

    Article  Google Scholar 

  22. Nguyen GC, Boudreau H, Harris ML, Maxwell CV . Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009; 7 (3): 329–334.

    Article  Google Scholar 

  23. Bush MC, Patel S, Lapinski RH, Stone JL . Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004; 15 (4): 237–241.

    Article  CAS  Google Scholar 

  24. Vessey M, Jewell D, Smith A, Yeates D, McPherson K . Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br Med J (Clin Res Ed) 1986; 292 (6528): 1101–1103.

    Article  CAS  Google Scholar 

  25. Klement E, Cohen RV, Boxman J, Joseph A, Reif S . Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 2004; 80 (5): 1342–1352.

    Article  CAS  Google Scholar 

  26. Das KM . Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44 (1): 1–13.

    Article  CAS  Google Scholar 

  27. Bernstein CN, Blanchard JF, Houston DS, Wajda A . The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85 (3): 430–434.

    Article  CAS  Google Scholar 

  28. Bernstein CN, Wajda A, Blanchard JF . The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008; 6 (1): 41–45.

    Article  Google Scholar 

  29. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006; 26 (7): 663–668.

    Article  Google Scholar 

  30. Adams DH, Eksteen B . Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006; 6 (3): 244–251.

    Article  CAS  Google Scholar 

  31. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009; 137 (2): 502–511.

    Article  Google Scholar 

  32. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004; 99 (4): 656–661.

    Article  Google Scholar 

  33. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J . Incidence and prevalence of inflammatory bowel diseasein a Northern California managed care organization, 1996-2002. Am J Gastroenterol 2008; 103 (8): 1998–2006.

    Article  Google Scholar 

  34. Loftus CG, Loftus EV Jr., Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13 (3): 254–261.

    Article  Google Scholar 

  35. Getahun D, Ananth CV, Oyelese Y, Chavez MR, Kirby RS, Smulian JC . Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet Gynecol 2007; 110 (6): 1319–1325.

    Article  Google Scholar 

  36. Hedderson MM, Gunderson EP, Ferrara A . Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010; 115 (3): 597–604.

    Article  Google Scholar 

  37. Buka SL, Shenassa ED, Niaura R . Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 2003; 160 (11): 1978–1984.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Daniel J Pinion for his technical support. This study was supported by Kaiser Permanente Direct Community Benefit Funds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D Getahun.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Getahun, D., Fassett, M., Longstreth, G. et al. Association between maternal inflammatory bowel disease and adverse perinatal outcomes. J Perinatol 34, 435–440 (2014). https://doi.org/10.1038/jp.2014.41

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.41

This article is cited by

Search

Quick links